Showing results (1821-1830 of 2,739) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|July 17, 2009
Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain managementPaul J Jannetto, Nancy C BratanowPharmacogenomics|September 19, 2009
Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysisMao Mao, Alice Matimba, Maria G Scordo, et al.Pharmacogenomics|June 4, 2011
Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black populationCathrine Mitchell, Nerine Gregersen, Amanda KrausePharmacogenomics|May 24, 2011
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogeneticsDaniel Sehrt, Ingolf Meineke, Mladen Tzvetkov, et al.Pharmacogenomics|December 23, 2011
Biomarker classifiers for identifying susceptible subpopulations for treatment decisionsWei-Jiun Lin, James J ChenPharmacogenomics|January 18, 2012
Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolismWei Zhang, Wei-Juan Zhang, Jin Zhu, et al.Pharmacogenomics|January 20, 2012
Genomic approach towards personalized anticancer drug therapyYutaka Midorikawa, Shingo Tsuji, Tadatoshi Takayama, et al.Pharmacogenomics|November 29, 2011
Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applicationsBritt I Drögemöller, Galen E B Wright, Dana J H Niehaus, et al.Pharmacogenomics|November 25, 2011
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patientsEkaterina Y Tsareva, Olga G Kulakova, Alexey N Boyko, et al.Pharmacogenomics|December 7, 2011
CYP2D6 and the severity of suicide attemptsEva M Peñas-Lledó, Hilario Blasco-Fontecilla, Pedro Dorado, et al.Pageof 274